• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • About Us
  • Our Laboratory
  • Contact Us
NPS Discovery
  • Reports
    • NPS Discovery Dashboard
    • Monographs
    • Trend Reports
    • Public Alerts
    • NPS Scope Recommendations
    • Drug Checking
    • Clinical Reports
    • NPS Discovery Toolkits
  • Resources
    • Publications
    • Presentations
    • Helpful Links
    • NPS in the News
  • CFSRE
Home Public Health Alert Synthetic Stimulant Market Rapidly Changing as N,N-Dimethylpentylone Replaces Eutylone in Drug Supply Typically Sold as “Ecstasy” or “Molly”

Synthetic Stimulant Market Rapidly Changing as N,N-Dimethylpentylone Replaces Eutylone in Drug Supply Typically Sold as “Ecstasy” or “Molly”

April 20, 2022

In 2020 and 2021, the substituted cathinone eutylone was the most commonly encountered synthetic stimulant to appear in forensic casework, despite the drug being considered federally scheduled as an isomer of pentylone since March 2017 according to the U.S. Drug Enforcement Administration (DEA). In September 2021, eutylone was recommended for international control. It is this notice that likely created a shift in the NPS drug market, which would later be noted by declining eutylone positivity and increasing N,N-dimethylpentylone positivity. N,N-Dimethylpentylone was first identified in toxicology samples in the U.S. in Q3 2021, marking the initial insurgence of this drug into the supply and the beginning of its proliferation. To date, N,N-dimethylpentylone has been identified in 32 toxicology cases, including antemortem and postmortem investigations, in addition to drug material cases. N,N-Dimethylpentylone is not explicitly scheduled in the U.S.; however, it could be considered an isomer of N-ethyl pentylone (Schedule I). Of note, pentylone is a metabolite of N,N-dimethylpentylone.

CLICK HERE TO ACCESS THE PUBLIC ALERT

Tags: Forensic, NPS, overdose, Postmortem, Public Health, Stimulant, Synthetic, Toxic, Toxicology, Trend

Reader Interactions

sidebar

Popular Tags

  • Opioids
  • Emergency Department
  • Heroin
  • Synthetic
  • Postmortem
  • opioid
  • Public Health
  • Clinical
  • drugs
  • philadelphia
  • Adulterant
  • Synthetic Opioid
  • overdose
  • Toxic
  • Fentanyl
  • NPS
  • Chemistry
  • Drug
  • Forensic
  • Toxicology

Meet Our Scientists

Alex J. Krotulski, PhD
Associate Director & Program Manager

Mandi L.A. Mohr, MSFS, D-ABFT-FT
Associate Director

Melissa F. Fogarty, MSFS, D-ABFT-FT
Laboratory Manager

Sara E. Walton, BS
Forensic Science Technician

Barry K. Logan, PhD, F-ABFT
Executive Director

Email Us At

npsdiscovery@cfsre.org

Contact Us

  • npsdiscovery@frfoundation.org
  • 215-366-1591

About Us

Newsroom

Follow Us


© 2022 The Center for Forensic Science Research & Education
  • Privacy Policy
  • Terms of Use
  • Sitemap